Frequently Asked Questions
What is the Proveris by Design™ process?
The Proveris by Design process is a patented, step-by-step testing protocol that begins with people and takes pharmaceutical spray and aerosol drug developers from pump selection to release testing for the life of a drug product. The process is rooted in Proveris’s deep understanding of regulatory guidelines and stems from Proveris’s experience helping global drug developers improve the quality of regulatory submission packages. What results? Better spray and aerosol drug products that start helping patients sooner than ever.
What is the Viota® software platform?
Proveris’s patented Viota software platform unifies laboratories and streamlines spray and aerosol test data management and analysis. Viota software controls all Proveris instrumentation and centralizes data records to enable access from anywhere in the world.
What is a Vereo® actuator?
Proveris’s patented Vereo automated actuators reliably replicate hand use of nasal and oral spray pumps and metered dose inhalers. Proveris has integrated a Vereo actuator into each piece of instrumentation it offers to ensure compliance with FDA recommendations for the use of automated actuation.
What is SprayVIEW® measurement instrumentation?
Proveris’s patented SprayVIEW instrument established the standard now recommended and used by the FDA for automated spray pattern and plume geometry measurement testing of spray and aerosol delivered drugs.
What is Indizo® high through-put instrumentation?
Proveris’s Indizo high through-put test instrumentation automates dose content uniformity and shot weight testing of nasal sprays. The robotic instrument provides pharmaceutical laboratories with the ability to conduct multiple high through-put routine tests of nasal spray devices using a single platform.